Gustavo Kourí
Biographic Data
| ID | 7017845 |
|---|---|
| NAME | Gustavo Kourí |
| GIVEN NAMES | Gustavo |
| FAMILY NAME | Kourí |
| SIGNATURE | KOURI G |
| AFFILIATIONS | Instituto de Medicina Tropical “Pedro Kourí” |
| VERIFIED | No |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1997 |
| LATEST PUBLICATION YEAR | 2008 |
| H-INDEX | 0 |
Estrategia de educación popular para promover la participación comunitaria en la prevención del dengue en Cuba
This strategy reduced mosquito vector infestation levels by increasing community participation in decision-making and strengthening the competencies of the medical teams and CWGs so that they lead participative processes in the community and raised confidence in their ability to achieve change with the appropriate resources and intersectoral support
El dengue y el dengue hemorrágico: Prioridades de investigación
Dengue is one of the most important infectious diseases in tropical and subtropical countries. At present, the only strategy available to reduce the incidence of dengue is vector control. The World Health Organization and the Pan American Health Organization have called on all nations to take the needed steps to help diminish the burden of this disease and its medical and socioeconomic impact. It is hoped that it will be possible to reverse the i…
Caracterización final y lecciones de la epidemia de dengue 3 en Cuba, 2001-2002
Over the past 10 years, the American Region has witnessed the reintroduction and dissemination of dengue virus serotype 3. In this paper we describe the main clinical and epidemiologic features of the dengue 3 epidemic that broke out in Cuba between June 2001 and March 2002, as well as the measures that were undertaken to eliminate it. A total of 14 524 confirmed cases were reported, 12 889 (88,7%) of them in the City of Havana. Eighty-one cases …
Control externo de la calidad del diagnóstico serológico del dengue en laboratorios de países de las Américas, 1996-2001
The majority of the participating laboratories showed an excellent level of performance in detecting dengue IgG and IgM antibodies. However, the deficiencies found in some instances confirm the need for continuing to improve laboratory diagnosis of dengue in the Region of the Americas
Enhanced severity of secondary dengue-2 infections: Death rates in 1981 and 1997 Cuban outbreaks
We found a marked increase in severity with the longer of the two intervals (20 years) between an initial DEN-1 infection and a secondary DEN-2 infection. Such a difference may be due to subtle shifts in causative dengue strains or to changes with the passage of time in the circulating population of human dengue antibodies. These observations have important implications for dengue control, pathogenic mechanisms, and vaccine development
La epidemiología del dengue y del dengue hemorrágico en Santiago de Cuba, 1997
A dengue epidemic that Cuba reported in 1997 registered more than 500,000 cases of dengue fever produced by viral serotype 1. In 1981, there was an epidemic of dengue hemorrhagic fever produced by serotype 2 of the virus. This time 344,203 clinical cases were reported, 10,312 of which were severe cases of hemorrhagic fever that led to 158 fatalities (101 of them among children). The reintroduction of dengue, and specifically of dengue viral serot…
Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro
This paper presents a standardized procedure for the detection of IgM antibodies to dengue virus in blood samples taken from filter paper. The samples were obtained from 118 patients, of whom 91 had been clinically diagnosed with dengue and 27 with a viral infection unrelated to that disease. The first group of patients came from Costa Rica and Nicaragua and the second group from Cuba. All the samples were tested for IgM antibody against dengue v…
Dengue in Nicaragua, 1994: Reintroduction of serotype 3 in the Americas
The principal aim of the report presented here is to describe the reappearance of dengue serotype 3 in the Americas, following a 17-year absence, through the recent experience of Nicaragua. In all, 356 serum samples obtained through Nicaragua's dengue monitoring system in October 1994 during an epidemic were examined. Anti-dengue IgM antibodies were detected in 43% of these, with sera from 12 of the 18 areas covered by Nicaragua's local integrate…
No prominent works on this page.
Dengue in Nicaragua, 1994: Reintroduction of serotype 3 in the Americas
The principal aim of the report presented here is to describe the reappearance of dengue serotype 3 in the Americas, following a 17-year absence, through the recent experience of Nicaragua. In all, 356 serum samples obtained through Nicaragua's dengue monitoring system in October 1994 during an epidemic were examined. Anti-dengue IgM antibodies were detected in 43% of these, with sera from 12 of the 18 areas covered by Nicaragua's local integrate…
Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro
This paper presents a standardized procedure for the detection of IgM antibodies to dengue virus in blood samples taken from filter paper. The samples were obtained from 118 patients, of whom 91 had been clinically diagnosed with dengue and 27 with a viral infection unrelated to that disease. The first group of patients came from Costa Rica and Nicaragua and the second group from Cuba. All the samples were tested for IgM antibody against dengue v…
La epidemiología del dengue y del dengue hemorrágico en Santiago de Cuba, 1997
A dengue epidemic that Cuba reported in 1997 registered more than 500,000 cases of dengue fever produced by viral serotype 1. In 1981, there was an epidemic of dengue hemorrhagic fever produced by serotype 2 of the virus. This time 344,203 clinical cases were reported, 10,312 of which were severe cases of hemorrhagic fever that led to 158 fatalities (101 of them among children). The reintroduction of dengue, and specifically of dengue viral serot…
Enhanced severity of secondary dengue-2 infections: Death rates in 1981 and 1997 Cuban outbreaks
We found a marked increase in severity with the longer of the two intervals (20 years) between an initial DEN-1 infection and a secondary DEN-2 infection. Such a difference may be due to subtle shifts in causative dengue strains or to changes with the passage of time in the circulating population of human dengue antibodies. These observations have important implications for dengue control, pathogenic mechanisms, and vaccine development
Control externo de la calidad del diagnóstico serológico del dengue en laboratorios de países de las Américas, 1996-2001
The majority of the participating laboratories showed an excellent level of performance in detecting dengue IgG and IgM antibodies. However, the deficiencies found in some instances confirm the need for continuing to improve laboratory diagnosis of dengue in the Region of the Americas
El dengue y el dengue hemorrágico: Prioridades de investigación
Dengue is one of the most important infectious diseases in tropical and subtropical countries. At present, the only strategy available to reduce the incidence of dengue is vector control. The World Health Organization and the Pan American Health Organization have called on all nations to take the needed steps to help diminish the burden of this disease and its medical and socioeconomic impact. It is hoped that it will be possible to reverse the i…
Caracterización final y lecciones de la epidemia de dengue 3 en Cuba, 2001-2002
Over the past 10 years, the American Region has witnessed the reintroduction and dissemination of dengue virus serotype 3. In this paper we describe the main clinical and epidemiologic features of the dengue 3 epidemic that broke out in Cuba between June 2001 and March 2002, as well as the measures that were undertaken to eliminate it. A total of 14 524 confirmed cases were reported, 12 889 (88,7%) of them in the City of Havana. Eighty-one cases …
Estrategia de educación popular para promover la participación comunitaria en la prevención del dengue en Cuba
This strategy reduced mosquito vector infestation levels by increasing community participation in decision-making and strengthening the competencies of the medical teams and CWGs so that they lead participative processes in the community and raised confidence in their ability to achieve change with the appropriate resources and intersectoral support
Mosquito-borne diseases and control (8 works) · Dengue fever (7 works) · Medicine (7 works) · Virology (7 works) · Dengue virus (6 works) · Viral Infections and Vectors (6 works) · Geography (4 works) · Dengue hemorrhagic fever (3 works) · Epidemiology (3 works) · Immunology (3 works)